5 Hemostatics for medical purposes; Pharmaceutical preparations, namely, elixirs for the treatment of nausea,anxiety, pain, glaucoma, seizures, multiple sclerosis, and Crohn's Disease; to the extent any of the foregoing involves cannabis, such cannabis shall have a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and non of the foregoing containing CBD; Plant extracts for pharmaceutical purposes